Home/Filings/4/0000950170-24-137860
4//SEC Filing

PASSERI DANIEL R 4

Accession 0000950170-24-137860

CIK 0001645460other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:00 PM ET

Size

5.0 KB

Accession

0000950170-24-137860

Insider Transaction Report

Form 4
Period: 2024-12-16
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2024-12-16$1.03/sh+30,000$30,900164,578 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.97 to $1.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range provided.

Documents

1 file

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001190121

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:00 PM ET
Size
5.0 KB